Addus HomeCare Corporation (ADUS) Income Statement

The sharp deceleration from the mid-20% range in late 2025 to high single digits in 2026 suggests that a meaningful portion of prior growth was inorganic. Investors should monitor whether the Gentiva-related footprint expansion can sustain growth without further tuck-in acquisitions. Absent that, the top line may increasingly depend on Medicaid rate increases and caregiver throughput rather than new market entry.

The stability of gross margin despite wage pressure suggests management has been able to pass through some reimbursement increases, but the tight range also reflects fixed state rate schedules. Because caregiver wages absorb most of the cost base, any mandated wage floor not fully reimbursed would likely compress this line quickly. The margin profile appears structurally constrained rather than expanding.

Operating income has not expanded meaningfully relative to revenue, which implies overhead is growing roughly in line with the top line. This pattern is consistent with a business where incremental caregiver-driven revenue carries similar administrative burden. Operating leverage may improve only if acquired offices are integrated into shared back-office infrastructure.